Ms. Soohyun Kang qualified as a Korean patent attorney in 2016 and specializes in intellectual property matters across the biotechnology, pharmaceutical, cosmetics, and food industries. Drawing upon her robust practical experience in patent law firms, along with her tenure as an in-house patent attorney for cosmetics, bio, food, and chemical companies, as well as university industry-academic cooperation foundations, she has a deep understanding of corporate business needs and delivers highly optimized, tailored IP solutions.
Through close partnerships with a diverse array of clients—including leading domestic and international pharmaceutical and chemical companies, national research institutes, university foundations, and promising startups—Ms. Kang has built extensive practical experience across the entire IP lifecycle. This includes patent prosecution, Office Action (OA) responses, and trials for invalidation and confirmation of scope. Furthermore, by collaborating closely from the early stages of R&D to analyze competitors\' patent trends, conducting freedom-to-operate (FTO) and infringement analyses, designing workarounds, and proposing strategies for building customized patent portfolios, she provides comprehensive IP consulting that goes beyond mere rights acquisition so as to actively drive successful commercialization.
Particularly, Ms. Kang holds a proven track record of successfully conducting patent due diligence and reviewing technology transaction agreements for technology transfers in the biotech and pharmaceutical sectors. She also possesses deep expertise in securing global patents in major jurisdictions, including the US, Europe, and Japan. With an integrated perspective that encompasses the entire IP lifecycle—from securing rights to technology commercialization and dispute resolution—she empowers clients to transform their core technologies into maximum business value.
EDUCATION
- Korea University (B.S. in Food Bioscience and Technology/Biotechnology, 2017)
WORK EXPERIENCE
- LEE & MOCK IP (2026-Present)
- IUCF. Hanyang University (2025-2026)
- Samyang Corp. (2022-2025)
- Cosmax BTI (2020-2022)
- LEE & MOCK IP (2019-2020)
- Hanol IP (2018)
ADMISSION
- Patent Attorney, Republic of Korea (2016)
LANGUAGES
- Korean, English, Chinese
KEY ACTIVITIES
REPRESENTATIVE MATTERS
- - Numerous patent mappings and FTO analyses in the biotechnology, pharmaceutical, and healthcare sectors, covering mRNA delivery systems, anticancer drugs, peptide therapeutics, diagnostic kits, viral vaccines, food materials, chemical materials, and cosmetics
- - Directed technology transfer brokering among industry, academia, and research institutes, while conducting due diligence for licensing in/out and reviewing technology transaction agreements (Term sheets, MTAs, NDAs, etc.) in the pharmaceutical and biotech sectors (2022-2026)
- - Performed IP-R&D projects related to mRNA delivery systems and medical devices including hemostatic agents and skin boosters (2022-2025)
- - Handled patent trials and invalidation appraisals to secure priority sales rights (first generic exclusivity) for anticancer drugs (2022-2025).
- - Conducted FTO analyses for cosmetic formulations and responded to patent disputes regarding microbiome materials (2020-2022)
- - Participated in InterBiz Bio Partnering (2020)
- - Participated in the Health Technology Licensing Office (TLO) project for breast cancer therapeutics, Asan Medical Center (2020)
- - Participated in the technology discovery coordination project, CHA Medical Center (2018-2020).
- - Conducted overseas patent rights analysis and design-around strategies for cosmetic compositions, LG Household & Health Care (2018)
- - Participated in the IP-R&D strategic project for pulmonary fibrosis therapeutics, Korea Institute of Radiological and Medical Sciences (2018)